The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.
about
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivoProfile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patientsBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingEffects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysisIdentification of differential responses to an oral glucose tolerance test in healthy adultsComparative Evaluation of Two Venous Sampling Techniques for the Assessment of Pancreatic Insulin and Zinc Release upon Glucose ChallengeEstimation of beta-cell function from the data of the oral glucose tolerance test.Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older womenInsulin-secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non-obese Japanese patientsA case-control analysis of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population.The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.Beta cell response to a mixed meal in nigerian patients with type 2 diabetes.Mice deficient in GEM GTPase show abnormal glucose homeostasis due to defects in beta-cell calcium handlingHigh passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation.Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia.Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity.The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation.Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.Monocyte chemoattractant protein 1 in obesity and insulin resistance.Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes.The Insulin Resistance but Not the Insulin Secretion Parameters Have Changed in the Korean Population during the Last Decade.Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), IkejaProlonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010).Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke.Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.Effect of laser acupuncture combined with a diet-exercise intervention on metabolic syndrome in post-menopausal womenA Unifying Organ Model of Pancreatic Insulin Secretion.First-phase insulin secretion: does it exist in real life? Considerations on shape and function.β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitusAtypical antipsychotic agents and increased risk of diabetes: class action or differential action?Advances in the treatment of prediabetes.Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion.A novel hierarchal-based approach to measure insulin sensitivity and secretion in at-risk populations.Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventionsSaturation of subcutaneous adipose tissue expansion and accumulation of ectopic fat associated with metabolic dysfunction during late and post-pubertal growth.Interactions between genetic background, insulin resistance and β-cell function.Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetesPersistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat.Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance.
P2860
Q24683214-2D30D822-96B7-48C8-8FEA-17322DD93A8FQ26824239-815FA950-01D8-4E5C-8518-6CFC193894EFQ26992979-C6D219F5-F5B6-40BB-88FC-3A7A2CF74765Q27009397-6103CD78-D76C-47FD-9693-F3B6C4ECF579Q28535572-E6B053E5-1523-4099-B760-CDE1B49C81F1Q30660557-52C915A9-40E7-4582-A80A-8167B22E8607Q33272514-B03944E9-2167-4056-AB1B-B91F10204A80Q33296042-BE4A0674-697F-44CF-850D-0064365ABFF9Q33585753-5B205E8A-EF88-4DD1-917A-1981A466A20FQ33645882-C6EBCD3F-F148-48D6-BC87-EC9D584BDE15Q34127704-D856DC0E-E032-40D2-A624-D4A9B1DA42A4Q34318757-B485F604-1C27-49E7-B070-2787A7D3C622Q34326149-120FA50D-2A49-4BDE-8D9E-C7D119513779Q34342487-D0DB53CF-ED17-4A17-B4FC-267F1D3D88F6Q34439517-9A1A372D-2CAD-4E27-9558-F41F8A730D1BQ34696555-BC0C4016-E39B-4579-A32C-EC11A15EFD2DQ35001130-96030670-3533-42F6-97B2-382849EE721DQ35065639-2747B3D7-FBEF-4171-A673-5CF96E33120EQ35163496-1F69FF8B-5E95-42EF-ABBA-7585FF4B1991Q35305506-5D0E6AF7-2C3E-4E4F-9ED7-C18EB64E1850Q35544013-6BFC6B02-8195-4D6B-B4B8-6BCDA40B3B5AQ35549916-195E47E4-7644-4E81-B1D1-77E98D2D6BDBQ35563100-7041A9D5-CA66-491E-8609-C5A452688A31Q35634417-FDF9DE95-EEA6-4ED6-ABAC-9E968833F62BQ35673977-472789D2-A37A-456D-BF3F-38A548DAC9E0Q35783714-A3053E21-4884-428C-8BCD-E9C91DC5530FQ35794685-5615D6C6-C92B-4E37-9FDC-40D4C0123D55Q35837641-1B50619C-5172-4428-B6D5-34A57E50A501Q35861874-E203E3C6-57F3-4172-8BB2-C79C80A87F7BQ35922968-2C63C089-03DE-49F0-9E79-D85C9C32C26EQ36040749-6E3C8DD7-8AE6-4BFB-A4F6-FF1961DCBFF8Q36327944-C17E48B8-0CD3-438F-852E-52F3DA8A64C8Q36509951-42BFA87F-3554-44E8-B632-4356C255883AQ36608947-15234002-24AD-4D4F-B9B2-B24C00A1D23CQ36740436-58577BF1-218B-4372-92D3-99587B4B4B51Q36767939-2E94D38A-0747-48DD-9DF3-B887DEDBA705Q36790858-CDCA70DE-4F5F-4E18-B89F-0C38D52DC6CAQ36899873-AE5DC319-E2D6-4EC8-8A1F-E2E3FD825736Q36943732-F2F8DF63-61AE-4689-B582-6A41AB3C3872Q37056930-FAA0D496-5445-409B-BAB8-B9210200C031
P2860
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of impaired early ins ...... of Type II diabetes mellitus.
@ast
The role of impaired early ins ...... of Type II diabetes mellitus.
@en
The role of impaired early ins ...... of Type II diabetes mellitus.
@nl
type
label
The role of impaired early ins ...... of Type II diabetes mellitus.
@ast
The role of impaired early ins ...... of Type II diabetes mellitus.
@en
The role of impaired early ins ...... of Type II diabetes mellitus.
@nl
prefLabel
The role of impaired early ins ...... of Type II diabetes mellitus.
@ast
The role of impaired early ins ...... of Type II diabetes mellitus.
@en
The role of impaired early ins ...... of Type II diabetes mellitus.
@nl
P921
P356
P1433
P1476
The role of impaired early ins ...... of Type II diabetes mellitus.
@en
P2093
P2888
P304
P356
10.1007/S001250100580
P577
2001-08-01T00:00:00Z
P5875
P6179
1051632962